ADC Therapeutics (ADCT) Other Operating Expenses: 2020-2022
Historic Other Operating Expenses for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to -$73,631.
- ADC Therapeutics' Other Operating Expenses rose 176.82% to $13.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $13.6 million, marking a year-over-year increase of 121.20%. This contributed to the annual value of -$73,631 for FY2022, which is 98.96% up from last year.
- ADC Therapeutics' Other Operating Expenses amounted to -$73,631 in FY2022, which was up 98.96% from -$7.1 million recorded in FY2021.
- In the past 5 years, ADC Therapeutics' Other Operating Expenses ranged from a high of -$22,101 in FY2020 and a low of -$7.1 million during FY2021.
- Over the past 3 years, ADC Therapeutics' median Other Operating Expenses value was -$73,631 (recorded in 2022), while the average stood at -$2.4 million.
- Its Other Operating Expenses has fluctuated over the past 5 years, first slumped by 31,863.14% in 2021, then skyrocketed by 98.96% in 2022.
- Yearly analysis of 3 years shows ADC Therapeutics' Other Operating Expenses stood at -$22,101 in 2020, then slumped by 31,863.14% to -$7.1 million in 2021, then spiked by 98.96% to -$73,631 in 2022.